Drugplain

Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night

aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate · KIT · Bayer HealthCare LLC.

No Recall History
Plain English

Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night is a kit containing aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate, taken oral. Manufactured by Bayer HealthCare LLC..

Key Facts

Brand Name
Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night
Generic Name
aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate
NDC Code (Product)
0280-0086
Manufacturer
Bayer HealthCare LLC.
Dosage Form
KIT
Route
ORAL
Marketing Status
Application #
M012
Marketing Start
04/27/2022

Recall History

No Recall History

Frequently Asked Questions

What is Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night used for?

Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night contains aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate. It is a kit taken oral. Consult your doctor for specific uses.

Is Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night a controlled substance?

Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night is not classified as a controlled substance by the DEA.

What is the generic name for Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night?

The generic name for Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night is aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate. There are 3 other brand versions of aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate.

What is the NDC code for Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night ?

The NDC (National Drug Code) for Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night is 0280-0086, listed by Bayer HealthCare LLC..

Product NDC

0280-0086

Package NDC

0280-0086-01

Other Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)